chronic fatigue

Grid List

Showing all 2 results

Cat’s Claw V-Max

R2,017.44 inc VAT

R2,017.44 inc VATAdd to cart

Cat’s Claw V-Max

R2,017.44 inc VAT

Cat’s Claw V-Max

Cat’s Claw V-Max is a targeted blend of botanicals and nutrients designed to support the body’s natural defenses against microbial stressors and facilitate a resilient immune response. Vitamin D3, liquid Cat’s Claw extract, lemon balm, olive leaf, propolis, monolaurin, and lemongrass oil help inhibit pathogen adherence, aid in pathogen clearance, and supports a productive immune response, making the body less hospitable to these common stressors. 

Pathogenic challenges, whether acute, latent, or ongoing, represent some of the most difficult cases to contend with in practice. Their ability to adapt and survive under multiple conditions requires an advanced and diverse approach. Cat’s Claw V-Max is a specially curated immune formulation combining well-researched nutrients and compounds to address such complex cases. 

NET WT 3.38 FL OZ (100mL) 

R2,017.44 inc VATAdd to cart

Crypto Co-Max

R2,521.80 inc VAT

R2,521.80 inc VATAdd to cart

Crypto Co-Max

R2,521.80 inc VAT

Crypto Co-Max

  • Synergistic Botanical Formula: Carefully selected plant compounds work together to enhance each other’s effects, providing a powerful and comprehensive health solution.
  • Broad Spectrum Microbial Support: Cryptolepis, Artemisinin, and Japanese Knotweed have been studied to be impactful on both active and persister vector-borne forms.*
  • Comprehensive Immune Support: Powerful botanicals help modulate the immune response to help combat the challenges of multiple pathogenic stressors.
  • Inflammation-Balancing Properties: Studies show that cryptolepine, an alkaloid found in the herb helps modulate the NF-kB pathway.*
  • Liposomal Delivery: Quicksilver’s liposomal technology supports the delivery of these potent botanicals to target vector-borne pathogens and their counterparts. A study on artemisinin showed that liposomal artemisinin has a longer half-life than non-liposomal artemisinin, prolonging its time in circulation.*

R2,521.80 inc VATAdd to cart